Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 known ✓ | P00915 | 4/20 | 0.40 |
| ▸ | CA2 known ✓ | P00918 | 4/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 2/20 | 0.35 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.35 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.35 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.35 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL17686587 | 0.97 | CA1 (0.38) | CA1CA2CA7CA9ACHE | |
| Water SCHEMBL2688804 | 0.97 | CA1 (0.38) | CA1CA2CA7CA9ACHE | |
| SCHEMBL689497 | 0.97 | CA1 (0.42) | CA1CA2CA7CA9ACHE | |
| Lithium Ion SCHEMBL1451658 | 0.93 | CA1 (0.40) | CA1CA2CA7CA9ACHE | |
| Silver SCHEMBL1451626 | 0.93 | CA1 (0.40) | CA1CA2CA7CA9ACHE | |
| Potassium Ion SCHEMBL3683077 | 0.93 | CA1 (0.40) | CA1CA2CA7CA9ACHE | |
| SCHEMBL6430652 | 0.93 | CA1 (0.40) | CA1CA2CA7CA9ACHE | |
| SCHEMBL912936 | 0.93 | CA1 (0.40) | CA1CA2CA7CA9ACHE | |
| SCHEMBL29853334 | 0.93 | CA1 (0.40) | CA1CA2CA7CA9ACHE | |
| Water SCHEMBL16539351 | 0.93 | CA1 (0.40) | CA1CA2CA7CA9ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024196901-A2 | A HIGH THROUGHPUT ION-SENSING METHOD | WHITESIDES GEORGE M (US) | 2024-09-26 | — | — | WO | claimed |
| CN-116995299-A | Sodium supplementing additive, sodium supplementing method and application of sodium supplementing additive in sodium ion battery | 天津中电新能源研究院有限公司 | 2023-11-03 | — | — | CN | claimed |
| EP-1034196-B1 | CATALYST AND METHODS FOR POLYMERIZING CYCLOOLEFINS | PROMERUS LLC (US) | 2005-01-12 | — | — | EP | claimed |
| US-20040180391-A1 | Sliver type autonomous biosensors | CASE WESTERN RESERVE UNIVERSITY | 2004-09-16 | — | — | US | claimed |
| WO-2004034032-A2 | SLIVER TYPE AUTONOMOUS BIOSENSORS | CASE WESTERN RESERVE UNIVERSITY (US) | 2004-04-22 | — | — | WO | claimed |
| US-20030023013-A1 | Catalyst and methods for polymerizing cycloolefins | THE B.F.GOODRICH COMPANY | 2003-01-30 | — | — | US | claimed |
| US-6455650-B1 | CONTACTING POLYCYCLOOLEFIN MONOMER WITH A HIGH ACTIVITY GROUP 10 TRANSITION METAL CATALYST COMPLEX TO OBTAIN POLYMER PRODUCT | THE B.F. GOODRICH COMPANY | 2002-09-24 | — | — | US | claimed |
| US-20020052454-A1 | CATALYST AND METHODS FOR POLYMERIZING CYCLOOLEFINS | SUMITOMO BAKELITE CO., LTD. (JP) | 2002-05-02 | — | — | US | claimed |
| EP-1034196-A1 | CATALYST AND METHODS FOR POLYMERIZING CYCLOOLEFINS | THE B.F. GOODRICH COMPANY (US) | 2000-09-13 | — | — | EP | claimed |
| WO-2000020472-A1 | CATALYST AND METHODS FOR POLYMERIZING CYCLOOLEFINS | THE B.F. GOODRICH COMPANY (US) | 2000-04-13 | — | — | WO | claimed |
| US-20260102222-A1 | DENTAL CURABLE COMPOSITION, DENTAL BLANK FOR CUTTING, METHOD OF PRODUCING A SILICA COMPOSITE OXIDE PARTICULATE, AND DENTAL FILLER | TOKUYAMA DENTAL CORP (JP) | 2026-04-16 | — | — | US | disclosed |
| WO-2025242625-A1 | TEST KIT FOR DETERMINING ANALYTES IN A SAMPLE OF A BODILY FLUID | F. HOFFMANN-LA ROCHE AG (CH) | 2025-11-27 | — | — | WO | disclosed |
| US-12421264-B2 | Compounds and methods for the treatment of pathogenic Neisseria | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2025-09-23 | — | — | US | disclosed |
| EP-4612126-A1 | COMPOSITIONS INCLUDING A MIXTURE OF ISOMERS OF ITACONIMIDE NORBORNENE AND CITRACONIMIDE NORBORNENE | 3M Innovative Properties Company (US) | 2025-09-10 | — | — | EP | disclosed |
| EP-4595944-A1 | DENTAL CURABLE COMPOSITION, BLANK FOR DENTAL-CUTTING WORK, PRODUCTION METHOD FOR SILICA-BASED COMPOSITE OXIDE POWDER BODY, AND DENTAL FILLER | Tokuyama Dental Corporation (JP) | 2025-08-06 | — | — | EP | disclosed |
| US-5922901-A | USING RUTHENIUM COMPLEX CATALYST | MITSUI CHEMICALS, INC. (JP) | 1999-07-13 | — | — | US | disclosed |
| US-5790627-A | Method and apparatus for observing a specimen using an X-ray microscope | RESEARCH DEVELOPMENT CORP. (JP) | 1998-08-04 | — | — | US | disclosed |
| EP-0795542-A1 | PROCESS FOR THE PRODUCTION OF ACRYLONITRILE DIMERS | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1997-09-17 | — | — | EP | disclosed |
| US-4790960-A | PRECIPITATION WITH SODIUM OR LITHIUM TERAPHENYLBORATES SUBSTIT UTED WITH ELECTRON-ATTRACTING GROUPS | KERNFORSCHUNGSZENTRUM KARLSRUHE GMBH (DE) | 1988-12-13 | — | — | US | disclosed |
| EP-0221508-A1 | Sodium ion selective electrode | HITACHI, LTD. (JP) | 1987-05-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102222-A1 | DENTAL CURABLE COMPOSITION, DENTAL BLANK FOR CUTTING, METHOD OF PRODUCING A SILICA COMPOSITE OXIDE PARTICULATE, AND DENTAL FILLER | RCC1, CA1, SSRP1 | CA1 2/4885CA2 549/4885CA7 93/4885 |
| US-12421264-B2 | Compounds and methods for the treatment of pathogenic Neisseria | NMBR, MLEC, BPGM | CA1 2869/4885CA2 2749/4885CA7 1642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.